Rituximab.
O'Neal
C
C
Euclid Hospital Cleveland Clinic Health System, Euclid, OH, USA.
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D016393:Lymphoma, B-Cell / Q000378:metabolism / Q000628:therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab